AHA Policy Statement Forecasting the Future of Cardiovascular Disease in the United States A Policy Statement From the American Heart Association
نویسندگان
چکیده
Paul A. Heidenreich, MD, MS, FAHA, Chair; Justin G. Trogdon, PhD; Olga A. Khavjou, MA; Javed Butler, MD, MPH, FAHA; Kathleen Dracup, RN, DNSc; Michael D. Ezekowitz, MBChB, DPhil, FRCP, FAHA; Eric Andrew Finkelstein, PhD, MHA; Yuling Hong, MD, PhD, FAHA*; S. Claiborne Johnston, MD, PhD, FAHA; Amit Khera, MD, MSc; Donald M. Lloyd-Jones, MD, MSc, FAHA; Sue A. Nelson, MPA; Graham Nichol, MD, MPH, FRCP(C), FAHA; Diane Orenstein, PhD*; Peter W.F. Wilson, MD, FAHA; Y. Joseph Woo, MD, FAHA; on behalf of the American Heart Association Advocacy Coordinating Committee, Stroke Council, Council on Cardiovascular Radiology and Intervention, Council on Clinical Cardiology, Council on Epidemiology and Prevention, Council on Arteriosclerosis, Thrombosis and Vascular Biology, Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation, Council on Cardiovascular Nursing, Council on the Kidney in Cardiovascular Disease, Council on Cardiovascular Surgery and Anesthesia, and Interdisciplinary Council on Quality of Care and Outcomes Research
منابع مشابه
Nonfinancial incentives for quality: a policy statement from the American Heart Association.
The American Heart Association (AHA) and its division, the American Stroke Association, are dedicated to improving the quality of care available to patients who have or are at risk of acquiring cardiovascular diseases, including stroke. Heart disease, stroke, and other cardiovascular diseases remain the No. 1 killer in the United States and a leading cause of permanent disability.1 Approximatel...
متن کاملAHA Policy Statement Genetics and Cardiovascular Disease A Policy Statement From the American Heart Association
Euan A. Ashley, MRCP, DPhil, Chair; Ray E. Hershberger, MD, Co-Chair; Colleen Caleshu, ScM, CGC; Patrick T. Ellinor, MD, PhD, FAHA; Joe G.N. Garcia, MD; David M. Herrington, MD, FAHA; Carolyn Y. Ho, MD; Julie A. Johnson, PharmD; Steven J. Kittner, MD, FAHA; Calum A. MacRae, MD, PhD; Gia Mudd-Martin, RN, MPH, PhD; Daniel J. Rader, MD, FAHA; Dan M. Roden, MD, FAHA; Derek Scholes, PhD; Frank W. Se...
متن کاملStatus of cardiovascular disease and stroke in Hispanics/Latinos in the United States: a science advisory from the American Heart Association.
BACKGROUND AND PURPOSE This American Heart Association (AHA) scientific statement provides a comprehensive overview of current evidence on the burden cardiovascular disease (CVD) among Hispanics in the United States. Hispanics are the largest minority ethnic group in the United States, and their health is vital to the public health of the nation and to achieving the AHA's 2020 goals. This state...
متن کاملForecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association.
BACKGROUND Cardiovascular disease (CVD) is the leading cause of death in the United States and is responsible for 17% of national health expenditures. As the population ages, these costs are expected to increase substantially. METHODS AND RESULTS To prepare for future cardiovascular care needs, the American Heart Association developed methodology to project future costs of care for hypertensi...
متن کاملAHA Policy Statement Value of Primordial and Primary Prevention for Cardiovascular Disease A Policy Statement From the American Heart Association
The process of atherosclerosis may begin in youth and continue for decades, leading to both nonfatal and fatal cardiovascular events, including myocardial infarction, stroke, and sudden death. With primordial and primary prevention, cardiovascular disease is largely preventable. Clinical trial evidence has shown convincingly that pharmacological treatment of risk factors can prevent events. The...
متن کامل